Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Clinical and ISO PLUS Peptide Solutions!

Our Clinical Peptide Solutions for You! Published on 19/03/2026 Focused on immunotherapy and cell therapy, ISO PLUS peptides meet higher regulatory standards than those required for research use. From Research to Clinical Development ISO PLUS peptides are desi

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Our Clinical Peptide Solutions for You!

Published on 19/03/2026

Focused on immunotherapy and cell therapy, ISO PLUS peptides meet higher regulatory standards than those required for research use.

From Research to Clinical Development

ISO PLUS peptides are designed to support projects from the early research stage all the way through translational and clinical stages. For customers planning cell- and immuno-therapeutic development, JPT also offers clinical-grade peptide manufacturing under strict quality standards.

While ISO PLUS peptides provide exceptional purity for advanced research, JPT’s clinical-grade peptides meet the stringent quality and regulatory requirements required for therapeutic development:

Specifications

ISO PLUS Peptides

Clinical Grade Peptides

Vendor qualification

x

Dedicated raw materials

Order dedicated personnel

ADCF policy

Certificate of analysis

Documented cleaning & calibration

Batch documentation & Coa (acc. IND)

Shippment control

Batch release

Key advantages include:

High purity peptide synthesis

Seamless transition from research-grade to clinical-grade production

Scalable

Expertise in complex and modified peptide sequences

Why Choose JPT?

With decades of experience in peptide synthesis, JPT supports researchers and biotech innovators worldwide with robust peptide solutions for discovery, preclinical, and clinical programs. If you are planning a project that requires clinical-grade peptides or scalable peptide manufacturing, our team would be happy to discuss your requirements.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Practical dosing example

Let's work through a complete example with BPC-157: Given: Peptide vial: 5mg BPC-157 Desired dose: 250mcg twice daily Reconstitution: 2mL bacteriostatic water Calculate concentration: 5mg ÷ 2mL = 2.5 mg/mL = 2,500 mcg/mL Calculate dose volume: 250mcg ÷ 2,500 mcg/mL = 0.1mL = 10 units Calculate vial duration: 5,000mcg total ÷ 500mcg/day = 10 days of doses At 10 units twice daily, the 2mL solution provides 10 days of doses. Since bacteriostatic water solutions remain stable for approximately 28 days refrigerated, this timeline works well.

Source: seekpeptides.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →